Standex International Corporation (NYSE: SXI) is a Industrials company (Industrial - Machinery) with a market capitalization of $2.8B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), Standex International Corporation had a Maz Rating of 4.21 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.56), among the strongest in its sector; its weakest was Valuation (1.56), more expensive than most of its sector. The other factors: Growth 4.24 (above most of its sector); Profitability 3.84 (above most of its sector); Financial Health 3.70 (above most of its sector). The current rating is for members: log in to see it.
At $229.92, Standex International Corporation trades at 24.5x trailing earnings, 3.1x sales and 3.6x book value, with an EV/EBITDA of 13.1. Over the last twelve months it generated about $902M of revenue and $113M of net income. It runs a gross margin of 42.4%, an operating margin of 22.1% and a net margin of 12.5%. It shows return on equity of 15.2%, return on invested capital of 11.4% and a free cash flow yield of 1.8%. On the balance sheet: a debt-to-equity ratio of 0.71 and a current ratio of 3.19. Over the past 52 weeks the share price ranged from $216.57 to $363.89, with a beta of 1.05.
Standex International Corporation pays a dividend yielding 0.60%, with 14% of earnings paid out. Its Maz Dividend Score is 3.63 out of 5, ranked against the other dividend payers in its sector (Safety 3.52, Growth 3.63, Yield 1.40, Consistency 4.31).
10 Wall Street analyst ratings cover the stock: 10 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Standex International Corporation (SXI) operates as a diversified global manufacturer and provider of products and services, catering to commercial and industrial markets across the United States and internationally. The company's operations are strategically organized into five key segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The Electronics division specializes in a wide array of sensors, including reed relays, fluid level, proximity, motion, flow, and HVAC condensate, along with custom electronic sensing solutions. It also delivers cutting-edge current sense and advanced planar transformer technologies, value-added assemblies, mechanical packaging, and bespoke wound transformers and inductors for both low and high-frequency applications. The Engraving segment offers mold texturizing, produces slush molding tools, provides roll engraving, and manufactures tooling for hygiene products and low observation vents. Additionally, it supplies project management and design services tailored for stealth aircraft, alongside process machinery for various industries. Within the Scientific segment, Standex develops and supplies temperature-controlled equipment, serving the medical, scientific, pharmaceutical, biotechnology, and broader industrial sectors. The Engineering Technologies segment is dedicated to providing comprehensive, customized net and near-net formed solutions for engineered components. These critical components are utilized across a wide spectrum of markets, including aviation, aerospace, defense, energy, industrial, medical, marine, oil and gas, and both manned and unmanned space applications. Finally, the Specialty Solutions segment focuses on the manufacturing and distribution of refrigerated, heated, and dry merchandising display cases. It also provides custom fluid pump solutions and produces single and double-acting telescopic and piston rod hydraulic cylinders. Established in 1955, Standex International Corporation maintains its headquarters in Salem, New Hampshire.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Standex International Corporation (SXI) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 15.9% / 30% · (Cash+Inv) / Mkt Cap (36m) 3.58% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 15.9% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.58% / 33% · Receivables / Mkt Cap (36m) 5.17% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 15.9% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.58% / 33.33% · Receivables / Mkt Cap (24m) 5.17% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 33.7% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 8.00% / 33.33% · Receivables / Avg Assets (4Q) 13.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 33.6% / 33.33% · (Cash+ST Inv) / Total Assets 7.59% / 33.33% · (Cash+Recv) / Total Assets 18.5% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Standex International Corporation (SXI) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Standex International Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Standex International Corporation reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q1 2027). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.